Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 12, 2021

SELL
$4.17 - $5.74 $96,156 - $132,358
-23,059 Closed
0 $0
Q1 2021

Apr 09, 2021

SELL
$5.28 - $9.64 $18,744 - $34,222
-3,550 Reduced 13.34%
23,059 $121,000
Q4 2020

Jan 08, 2021

SELL
$5.75 - $7.13 $28,692 - $35,578
-4,990 Reduced 15.79%
26,609 $173,000
Q3 2020

Oct 05, 2020

BUY
$4.9 - $7.12 $4,165 - $6,052
850 Added 2.76%
31,599 $193,000
Q2 2020

Jul 06, 2020

BUY
$6.43 - $9.86 $4,629 - $7,099
720 Added 2.4%
30,749 $223,000
Q1 2020

Apr 06, 2020

BUY
$6.36 - $10.05 $30,210 - $47,737
4,750 Added 18.79%
30,029 $208,000
Q4 2019

Jan 07, 2020

SELL
$8.49 - $12.81 $4,270 - $6,443
-503 Reduced 1.95%
25,279 $222,000
Q3 2019

Oct 02, 2019

BUY
$5.58 - $14.47 $79,146 - $205,242
14,184 Added 122.3%
25,782 $288,000
Q2 2019

Jul 23, 2019

BUY
$5.22 - $9.08 $417 - $726
80 Added 0.69%
11,598 $70,000
Q1 2019

Apr 09, 2019

BUY
$5.35 - $9.82 $214 - $392
40 Added 0.35%
11,518 $90,000
Q4 2018

Jan 10, 2019

BUY
$3.43 - $6.19 $5,196 - $9,377
1,515 Added 15.21%
11,478 $56,000
Q3 2018

Oct 09, 2018

BUY
$4.75 - $14.5 $665 - $2,030
140 Added 1.43%
9,963 $47,000
Q2 2018

Jul 10, 2018

BUY
$13.3 - $17.45 $1,064 - $1,396
80 Added 0.82%
9,823 $133,000
Q1 2018

Apr 19, 2018

BUY
$14.7 - $24.95 $55,860 - $94,810
3,800 Added 63.94%
9,743 $156,000
Q4 2017

Jan 19, 2018

BUY
$19.9 - $29.25 $2,587 - $3,802
130 Added 2.24%
5,943 $137,000
Q3 2017

Oct 16, 2017

BUY
$15.1 - $19.25 $87,776 - $111,900
5,813
5,813 $107,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.